“Hey Syre Shareholders and Investors, Did You Lose Money on Spyre? We’ve Got Your Attention!”
Life in the Big Apple just got a little more interesting with the news surrounding Spyre Therapeutics, Inc. Investors are on edge as Levi & Korsinsky launch an investigation into possible violations of federal securities laws by the company. According to a recent filing with the U.S. Securities and Exchange Commission, Spyre disclosed that their…